|
ADI-001 Clinical Trials
2 actively recruiting trials across 1 location
Pipeline
Phase 1: 2
Top Sponsors
- Adicet Therapeutics2
Indications
- ANCA Associated Vasculitis (AAV)1
- Rheumatoid Arthritis (RA1
- Lupus Nephritis1
- Systemic Sclerosis (SSc)1
- Systemic Lupus Erythematosus (SLE)1
Other1 trial
Redwood City, California1 trial
A Phase 1 Study of ADI-001 in Autoimmune Disease
Adicet Clinical Trials
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.